Jetrea: New intraocular injection8:44 PM
Optometrists or students that are blog readers, this post is for you! I just found out about an interesting new ophthalmic medication that is undergoing clinical research. Jetrea is a new intravitreal injection designed for patients with symptomatic vitreomacular traction. The medication is a specific enzyme lysing agent, designed to breakdown the connection between the vitreous and the retina underneath. This injection could be utilized in patients with vitreal traction resulting in an epiretinal membrane or an impending macular hole. At this point, research is early, and is just starting to be used in research surgery centers.
|Photo via retinadoctor.com.au|
This OCT image shows the vitreous (thin superior line) attaching erroneously to the macula and distorting upward. There is a risk for a macular hole to develop if the traction continues.